help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Homma, K.
Right arrow Articles by Matsuo, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Homma, K.
Right arrow Articles by Matsuo, N.
Right arrowPubmed/NCBI databases
*OMIM
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*17ALPHA-HYDROXYPROGESTERONE
*Genetics Home Reference
Medline Plus Health Information
*Premature Babies
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 12 6087-6091
Copyright © 2004 by The Endocrine Society

Elevated Urine Pregnanetriolone Definitively Establishes the Diagnosis of Classical 21-Hydroxylase Deficiency in Term and Preterm Neonates

Keiko Homma, Tomonobu Hasegawa, Eiko Takeshita, Kiyoaki Watanabe, Makoto Anzo, Takio Toyoura, Kazuhiko Jinno, Toya Ohashi, Takashi Hamajima, Yukihiro Takahashi, Takao Takahashi and Nobutake Matsuo

Department of Laboratory Medicine (K.H., E.T., K.W.), and Department of Pediatrics (T.Has., M.A., T.Ta., N.M.), Keio University School of Medicine, Tokyo 160-8582, Japan; Tokyo Metropolitan Kiyose Children’s Hospital (M.A.), Tokyo 204-0022, Japan; Department of Pediatrics (T.To.), Tokyo Medical and Dental University, Tokyo 113-8519, Japan; Department of Pediatrics (K.J.), Division of Medical Intelligence and Informatics, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551, Japan; Department of Pediatrics (T.O.), The Jikei University School of Medicine, Tokyo 105-8471, Japan; Department of Endocrinology (T.Ham.), Aichi Children’s Health and Medical Center, Aichi 474-0031, Japan; Division of Neonatal Intensive Care (Y.T.), Center of Perinatal Medicine, Nara Medical University Hospital, Nara 634-8522, Japan; and National Center for Child Health and Development (N.M.), Tokyo 157-8535, Japan

Address all correspondence and requests for reprints to: Keiko Homma, Department of Laboratory Medicine, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail: keikoh{at}happy.email.ne.jp.

Elevated blood 17{alpha}-hydroxyprogesterone (17OHP) level, although widely used for the screening of classical 21-hydroxylase deficiency (21OHD) in neonates, has frequently been found in some neonates without classical 21OHD, particularly preterm neonates. We studied the diagnostic value of the metabolite of 21-deoxycortisol (pregnanetriolone, Ptl) and the metabolite of 17OHP (pregnanetriol, PT) in identifying 21OHD in term and preterm neonates with elevated blood 17OHP on the newborn screening.

Spot urine samples from 59 classical 21OHD neonates (50 term, 9 preterm), 83 neonates without 21OHD having transiently elevated blood 17OHP (non-21OHD) (49 term, 34 preterm), and 62 control term neonates were studied using gas chromatography/mass spectrometry in selected ion monitoring analysis for Ptl, PT, 5ß-tetrahydrocortisone (ßTHE), and 5{alpha}-tetrahydrocortisone ({alpha}THE).

Ptl and Ptl/(ßTHE+{alpha}THE) showed no overlap between 21OHD and non-21OHD, and 21OHD and controls, respectively (Ptl was 0.46–124 mg/g creatinine in 21OHD term, 0.80–26.9 mg/g creatinine in 21OHD preterm, less double equals0.08 mg/g creatinine in non-21OHD term, less double equals0.06 mg/g creatinine in non-21OHD preterm, and less double equals0.07 mg/g creatinine in controls). PT and PT/(ßTHE+{alpha}THE) showed significant overlap between 21OHD and non-21OHD.

The above data indicate that spot urine Ptl is a highly specific marker of 21OHD with a cutoff value of 0.1 mg/g creatinine, yielding an unambiguous separation between 21OHD and non-21OHD in term and preterm neonates.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
K. Homma, T. Hasegawa, T. Nagai, M. Adachi, R. Horikawa, I. Fujiwara, T. Tajima, R. Takeda, M. Fukami, and T. Ogata
Urine Steroid Hormone Profile Analysis in Cytochrome P450 Oxidoreductase Deficiency: Implication for the Backdoor Pathway to Dihydrotestosterone
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2643 - 2649.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society